作者
Shijun Ren, Eric J Lien, Nicholas C Turner, John C Clapham, Laszlo Prokai, Ravenska TE Wagey, Charles Krieger, Vera M Kolb, Kirk W Johnson, Lee A Phebus, Marlene L Cohen, Barry A Kenny, Mark Bushfield, David J Parry-Smith, Simon Fogarty, J Mark Treherne, Nicholas C Turner, John C Clapham
发表日期
1998
来源
Progress in Drug Research
页码范围
33-94
出版商
Birkhäuser Basel
简介
Impaired glucose tolerance and non-insulin-dependent diabetes (NIDDM) are the pathologic consequences of two co-incident and interacting conditions, namely insulin resistance and relative insulin deficiency. Recognised by the World Health Authority as a global health problem there are at 1995 estimates at least 110 million diagnosed diabetics world wide with at least the same number undiagnosed. Diabetes is the 4th leading cause of death in developed countries and its management exerts a vast economic and social burden. Insulin resistance is established as the characteristic pathologic feature of patients with glucose intolerance and NIDDM describing a state in which insulin stimulated glucose uptake and utilisation in liver, skeletal muscle and adipose tissue is impaired and coupled to impaired suppression of hepatic glucose output. Although the biochemical mechanisms underpinning both …
引用总数
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202014583349468424115324211